Riskpilot← Back to searchSign inGet full accessSYNSSENTERET AS
ASActiveOrg 996241254Ringveien 26, 9300 FinnsnesRetail sale of medical and orthopaedic goods · NACE 4774Est. 201013 employees
Revenue 2024
NOK 14,8M
+2% vs 2023
EBITDA margin
13.1%
-4% vs 2023
Equity ratio
40.4%
Financial strength
Net profit 2024
NOK 1,4M
+17% vs 2023
| Revenue | NOK 14,8M | +2% |
| EBITDA | NOK 1,9M | -4% |
| Net profit | NOK 1,4M | +17% |
| Total assets | NOK 5,1M | -3% |
| Equity | NOK 2,1M | +25% |
| Employees | 13 | — |
Legal name
SYNSSENTERET AS
Org number
996241254
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
30. november 2010
Share capital
NOK 100 000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Utgår
Company purpose
Optisk virksomhet, og hva hermed står i forbindelse, herunder å delta i andre selskaper med liknende virksomhet.
Address
Ringveien 26, 9300 Finnsnes
Phone
+4777840885
Email
finnsnes@no.specsavers.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 11 438 | 16 592 | 12 922 | 14 570 | 14 829 |
| Staff expenses | −3 607 | −3 687 | −4 355 | −4 548 | −4 775 |
| EBITDA | 2 061 | 5 980 | 1 633 | 2 015 | 1 940 |
| Depreciation & amort. | −418 | −500 | −604 | −720 | −538 |
| EBIT | 1 643 | 5 480 | 1 028 | 1 294 | 1 402 |
| Net financials | 22 | 132 | 52 | 256 | 327 |
| Profit before tax | 1 665 | 5 612 | 1 080 | 1 550 | 1 729 |
| Tax | 366 | 1 227 | 227 | 350 | 323 |
| Net profit | 1 299 | 4 386 | 853 | 1 200 | 1 406 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 306 | 6 802 | 6 956 | 5 243 | 5 087 |
| Equity | 1 402 | 1 497 | 1 850 | 1 650 | 2 056 |
| Long-term debt | 0 | 392 | 302 | 192 | 116 |
| Short-term debt | 3 904 | 4 913 | 4 804 | 3 401 | 2 914 |
| Total debt | 3 904 | 5 305 | 5 106 | 3 593 | 3 031 |
EBITDA margin
13.1%
This company
15.8%
Market median
-17% vs market
20202024
Equity ratio
40.4%
This company
38.2%
Market median
+6% vs market
20202024
Return on equity
68.4%
This company
18.4%
Market median
+272% vs market
20202024
Net profit margin
9.5%
This company
8.1%
Market median
+17% vs market
20202024
Asset turnover
2.92×
This company
1.12×
Market median
+161% vs market
20202024
Debt / equity
1.47×
This company
0.62×
Market median
-137% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KB Chief Executive Officer | Chief Executive Officer | 2019 |
SK Deputy Member | Deputy Member | 2019 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bjørkeng Holding As
SYNSSENTERET AS Board members of SYNSSENTERET AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjetil Bjørkeng | Chief Executive Officer | 0 companies |
| Silje Karoline Larsen Bjørkeng | Deputy Member | 0 companies |